ertapenem has been researched along with Pneumonia, Bacterial in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, JA; Coe, KE; Elefritz, JL; Fussner, LA; Holsen, MR; Wardlow, LC | 1 |
| Doi, Y; Qureshi, ZA; Syed, A | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Artero, A; Atienza, A; Correa, S; Faus, A; López, I; Madrazo, M; Puchades, F | 1 |
| Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF | 1 |
| Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R | 1 |
| Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
| Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ | 1 |
| Burkhardt, O; Derendorf, H; Kielstein, JT; Kumar, V; Schmidt, S; Welte, T | 1 |
| Bartizal, KF; Hicks, PS; Motyl, M; Pelak, B; Woods, GL | 1 |
| Carides, A; Friedland, I; Isaacs, R; Ortiz-Ruiz, G; Vetter, N; Woods, GL | 1 |
| DiNubile, MJ; Friedland, IR; McCarroll, KA; Woods, GL | 1 |
| Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W | 1 |
| Brink, AJ; Elliott, E; Els, Z; Livermore, DM; Turton, J; van Greune, J; Warner, M; Woodford, N | 1 |
| Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
| Joseph, J; Rodvold, KA | 1 |
| Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL | 1 |
4 review(s) available for ertapenem and Pneumonia, Bacterial
| Article | Year |
|---|---|
Health care-associated pneumonia: identification and initial management in the ED.
Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline | 2008 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
Appropriate use of the carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections | 2004 |
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
4 trial(s) available for ertapenem and Pneumonia, Bacterial
| Article | Year |
|---|---|
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 2009 |
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2004 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
9 other study(ies) available for ertapenem and Pneumonia, Bacterial
| Article | Year |
|---|---|
Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2019 |
Safety and efficacy of long-term outpatient ertapenem therapy.
Topics: Adult; Aged; Arthritis, Infectious; beta-Lactams; Bone and Bones; Cohort Studies; Ertapenem; Follow-Up Studies; Humans; Intraabdominal Infections; Middle Aged; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Skin; Soft Tissue Infections; Surgical Wound Infection; Treatment Outcome; Young Adult | 2014 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
Ertapenem therapy for pneumonia requiring hospital admission in elderly people.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Ertapenem; Female; Hospital Mortality; Hospitalization; Humans; Male; Patient Discharge; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2016 |
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial | 2010 |
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Ertapenem; Humans; Monte Carlo Method; Plasma; Pneumonia, Bacterial | 2010 |
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Bronchitis, Chronic; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2002 |
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Female; Haemophilus influenzae; Hospitalization; Humans; Injections, Intravenous; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Streptococcus pneumoniae; Treatment Outcome | 2004 |
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2006 |